Despite the initial enthusiasm in Aurora kinase targeting (addressed later in the review), which was supported by their overexpression in AML cells, some concerns have been raised, due to the induction of polyploidy [57] which can occur in the absence of P53-mediated surveillance. The gene discussed is TP53; the disease is acute myeloid leukemia.